Szymon Drygała

Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study)

E. Poniewierka, H. Cichoż-Lach, A. Kaczka, 2021, Therapeutic advances in gastroenterology.